March 20 2013


Alexander Kel, CSO of geneXplain, presented at an Open Session of the SYSCOL project in Oxford, UK.


Edgar Wingender, CEO of geneXplain, lectures at the VIIth International Congress on “Biotechnology: State of the Art and Prospects of Development” in Moscow about “Construction of gene regulatory networks of cardiomyocyte differentiation”.